These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 25901549)
1. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database. Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549 [TBL] [Abstract][Full Text] [Related]
2. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. MacLaren R; Reynolds PM; Allen RR JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015 [TBL] [Abstract][Full Text] [Related]
3. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH. Tofil NM; Benner KW; Fuller MP; Winkler MK J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049 [TBL] [Abstract][Full Text] [Related]
4. Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study. Duffett M; Chan A; Closs J; McGloin R; McKelvie G; Pong S; Seto W; Slaney H; Vaninetti G; Vanniyasingam T Pediatr Crit Care Med; 2020 Feb; 21(2):e107-e113. PubMed ID: 31821206 [TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630 [TBL] [Abstract][Full Text] [Related]
6. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals. Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401 [TBL] [Abstract][Full Text] [Related]
7. What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors? Patel AJ; Som R Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):356-60. PubMed ID: 23208652 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494 [TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease. Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*. MacLaren R; Campbell J Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863 [TBL] [Abstract][Full Text] [Related]
12. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors. Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195 [TBL] [Abstract][Full Text] [Related]
13. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Steinberg KP Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662 [TBL] [Abstract][Full Text] [Related]
14. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol. Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM; Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780 [TBL] [Abstract][Full Text] [Related]
15. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding. Sochet AA; Son S; Ryan KS; Roddy M; Barrie E; Wilsey M; McKinley SD; Nakagawa TA J Asthma; 2020 Aug; 57(8):858-865. PubMed ID: 31046509 [No Abstract] [Full Text] [Related]
16. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. Cook D; Guyatt G N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497 [No Abstract] [Full Text] [Related]
17. [Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors]. Tank S; Kerner T Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1338. PubMed ID: 24914510 [No Abstract] [Full Text] [Related]
18. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists. Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805 [TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis for stress ulcer bleeding in the intensive care unit]. Avendaño-Reyes JM; Jaramillo-Ramírez H Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722 [TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke. Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]